Back to search results
NCT07634653

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

Recruiting
NAAges 6+InterventionalSupportive care
UNC Lineberger Comprehensive Cancer Center
~40 participants
Updated 2026-08-03 on ClinicalTrials.gov
What's tested:Exercises

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of subjects completed exercise intervention
Measured over Up to 9 weeks

Conditions

Leukemia
Acute Leukemia
Acute Lymphoid Leukemia
Lymphoblastic Lymphoma
Acute Lymphoblastic Leukemia

Explore related trials

Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma

NCT07634653

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolinastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Thomas Alexander, MD, MPH · PRINCIPAL_INVESTIGATOR · UNC Lineberger Comprehensive Cancer Center

Who to contact

Jessica Buddenbaum, MS
[email protected]
919-966-4432
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information. OR Written assent and parental/legal guardian consent.
Age \>= 6 and \< =21 years at the time of diagnosis.
Newly- diagnosed with one of the following diseases: B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Written informed consent to participate in the caregiver interviews.
The caregiver must be a parent or legal guardian ≥ 18 years old, and their child must be \<18 years

Exclusion

Subjects must not be receiving any investigational or additional anti-cancer medicines during induction.
Significant concurrent disease, illness, or psychiatric disorder or social issue that would compromise subject safety or adherence to the protocol treatment or procedures, interfere with consent, study participation, follow-up, or interpretation of the study results.

What this trial measures

  • Proportion of subjects completed exercise interventionUp to 9 weeks

    The proportion of subjects who attend at least 16 of 24 total (3 per week) exercise sessions and complete ≥ 60% of the prescribed exercise plan.